tiprankstipranks
Hisamitsu Pharmaceutical Co Inc (HTSUF)
OTHER OTC:HTSUF
US Market

Hisamitsu Pharmaceutical Co (HTSUF) Income Statement

Compare
5 Followers

Hisamitsu Pharmaceutical Co Income Statement

Last quarter (Q2 2024), Hisamitsu Pharmaceutical Co's total revenue was ¥39.65B, an increase of 13.66% from the same quarter last year. In Q2, Hisamitsu Pharmaceutical Co's net income was ¥4.31B. See Hisamitsu Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 141.71B¥ 128.33B¥ 120.19B¥ 114.51B¥ 140.99B
Gross Profit
¥ 78.97B¥ 72.70B¥ 70.07B¥ 69.17B¥ 87.60B
Operating Expenses
¥ 65.80B¥ 61.10B¥ 60.73B¥ 58.50B¥ 64.88B
Depreciation and Amortization
¥ 5.17B¥ 4.95B¥ 4.32B¥ 4.08B¥ 4.25B
EBITDA
¥ 24.37B¥ 16.55B¥ 13.66B¥ 14.75B¥ 26.98B
Operating Income
¥ 13.17B¥ 11.60B¥ 9.34B¥ 10.67B¥ 22.73B
Other Income/Expenses
¥ 6.02B¥ 4.51B¥ 3.62B¥ 1.53B¥ 3.43B
Pretax Income
¥ 19.19B¥ 16.11B¥ 12.96B¥ 12.20B¥ 26.16B
Net Income
¥ 13.97B¥ 11.74B¥ 9.66B¥ 9.25B¥ 18.69B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 181.61¥ 148.00¥ 118.92¥ 113.21¥ 227.58
Diluted EPS
¥ 181.41¥ 147.87¥ 118.84¥ 113.10¥ 227.30
Weighted Average Shares Outstanding
76.92M 79.34M 81.21M 81.71M 82.14M
Weighted Average Shares Outstanding (Diluted)
77.00M 79.41M 81.27M 81.79M 82.25M
Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis